| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.039 | 0.5 |